A study on the expression of BRCA1 & P53 and their correlation in epithelial ovarian cancer

Chinese Journal of Clinical Oncology

Volumn 32, Issue 1, 2005, Pages 18-20

  Yu, Ming ^a   Hao, Jihui ^a   Jiao, Zhenshan ^a  

^a KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

Author keywords

BRCA1; Clinical pathological parameters; Immunohistochemistry; Ovarian epithelium cancer; p53; Survival analysis

Indexed keywords

BRCA1 PROTEIN; PROTEIN P53;

ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; OVARY CANCER; PELVIS LYMPH NODE; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR GROWTH;

EID: 19544374106     PISSN: 10008179     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 [J]. Science, 1994, 266(5182): 66-71
2. Meng QH, Yuan RQ, Goldberg ID, et al. BRCAlis differentially expressed in human tumor cells [J]. Shi Yan Sheng Wu Xue Bao, 2001, 34(1): 55-64
3. Callebaut I, Mornon JP. From BRCA1 to RAP1: a widespeard BRCT module closely associated with DNA repair [J]. FEBS lett, 1997, 400(1): 25-30
4. Daniel DC. Highlight: BRCA1 and BRCA2 proteins in breast cancer[J]. Microsc Res Tech, 2002, 59(1): 68-83
5. Ekblad CM, Wilkinson HR, Schymkowitz JW, et al. Characterisation of the BRCT domains of the breast cancer susceptibility gene product BRCA1[J]. J Mol Biol, 2002, 320(3): 431-442
6. Signori E, Bagni C, Papa S, et al. A somatic mutation in the 5'UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency [J]. Oncogene, 2001, 20(33): 4596-4600
7. Jarvis EM, Kirk JA, Clarke CL. Loss of nuclear BRCA1 expression in breast cancer is associated with a highly proliferative tumor phenotype[J]. Cancer Genet Cytogenet, 1998, 101(2): 109-115
8. Johnson SM, Shaw JA, Walker RA. Sporadic breast cancer in young women: prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2[J]. Int J Cancer, 2002, 98(2): 205-209
9. Lakhani SR, van De Vijver MJ, Jacquemier J, et al. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2[J]. J Clin Oncol, 2002, 20(9): 2310-2318
10. Buller RE, Shahin MS, Geisler JP, et al. Failure of BRCA1 dysfunction to alter ovarian cancer survival [J]. Clin Cancer Res, 2002, 8(5): 1196-1202
11. Rose SL, Buller RE. The role of p53 mutation in BRCAl-associated ovarian cancer[J]. Minerva Ginecol, 2002, 54(3): 201-209
12. Greenblatt MS, Chappuis PO, Bond JP, et al. TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution [J]. Cancer Res, 2001, 61(10): 4092-4097
13. Eisinger F, Nogues C, Birnbaum D, et al. Low-frequency of lymphnode metastasis in BRCA1 -associated breast cancer [J]. Lancet, 1998, 351(9116): 1633-1634